L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor
B. V. Jardim-Perassi, P. Irrera, D. Abrahams, V. C. Estrella, B. Ordway, S. R. Byrne, A. A. Ojeda, C. J. Whelan, J. Kim, M. S. Beatty, S. Damgaci-Erturk, D. L. Longo, K. J. Gaspar, G. M. Siegers, B. A. Centeno, , A. Ibrahim-Hashim
This study shows that L-DOS47, a urease immunoconjugate, enhances anti-PD1 immunotherapy efficacy in pancreatic cancer by neutralizing tumor acidity.
bioRxiv · Aug 28, 2023 · PreprintCancer Biology